Within the last years, SQ infusion of an increasing number of drugs has been described to have favorable outcomes with regards to effectiveness, safety, acceptability, and efficiency in the pediatric and adult population [12]
The sooner regulation becomes crystal clear, the sooner those interested in incorporating peptides into their daily routines will be able to explore how they can best optimise their results
Tissue Eng A
conceived of the idea, designed the study, contributed reagents/materials and wrote the manuscript
Potential side effects may include injection-site redness, swelling, bruising, itching, tenderness, small lumps, headache, fatigue, nausea, appetite changes, abdominal discomfort, stool changes, dizziness, altered sleep, mood changes, or feeling off. Allergic or immune reactions are also possible, and the FDA has specifically raised concerns about immunogenicity and peptide-related impurities in compounded BPC-157